Discover an ulcerative colitis (UC) therapy that may help keep your UC in remission
In clinical trials,
Once-daily APRISO maintained UC remission for up to 6 months in a majority of patients
Four APRISO capsules (1.5 g total) were taken once a day in the morning and helped patients 18 years of age or older with UC stay symptom free for up to 6 months. APRISO can be taken with or without food.
APRISO capsules are made with a special INTELLICOR technology, which allows the medication to be released slowly in your body over time. This special technology is designed to reach the colon and work right at the source of UC symptoms and "flare-ups."
The safety and efficacy of APRISO for treating UC beyond 6 months has not been evaluated in controlled clinical trials.
SELECTED IMPORTANT SAFETY INFORMATION
You should not take APRISO extended-release capsules if you experience an allergic reaction to salicylates or aminosalicylates, or to any of the components of APRISO capsules.
Kidney impairment has been reported in patients given products like APRISO (contain mesalamine or are converted to mesalamine). It is recommended that you have an evaluation of kidney function prior to treatment with APRISO therapy and periodically while on therapy. Talk to your doctor if you have any kidney problems before taking APRISO.
Please see below for complete Important Safety Information.
Please click here for full Prescribing Information for APRISO extended-release capsules.